NDC properties for NDC 9 55513-481
NDC item 55513048101
NDC 9 | 55513-481 |
---|---|
NDC 10 | 55513-481-01 |
NDC Item | 55513048101 |
packaging | 1 SYRINGE in 1 CARTON (55513-481-01) / .8 mL in 1 SYRINGE |
BLA | BLA761024 |
FDA SPL set id | 807577 |
Labeler | Amgen Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2023-08-14 |
Marketing status | ACTIVE |
NDC item 55513048102
NDC 9 | 55513-481 |
---|---|
NDC 10 | 55513-481-02 |
NDC Item | 55513048102 |
packaging | 2 SYRINGE in 1 CARTON (55513-481-02) / .8 mL in 1 SYRINGE |
BLA | BLA761024 |
FDA SPL set id | 807577 |
Labeler | Amgen Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2023-08-14 |
Marketing status | ACTIVE |
NDC item 72511048101
NDC 9 | 72511-481 |
---|---|
NDC 10 | 72511-481-01 |
NDC Item | 72511048101 |
BLA | BLA761024 |
FDA SPL set id | 828840 |
Labeler | Amgen USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2023-08-14 |
Marketing status | ACTIVE |
NDC item 72511048102
NDC 9 | 72511-481 |
---|---|
NDC 10 | 72511-481-02 |
NDC Item | 72511048102 |
packaging | 2 SYRINGE in 1 CARTON (72511-481-02) / .8 mL in 1 SYRINGE |
BLA | BLA761024 |
FDA SPL set id | 828840 |
Labeler | Amgen USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2023-08-14 |
Marketing status | ACTIVE |
NDC item 84612048101
NDC 9 | 84612-481 |
---|---|
NDC 10 | 84612-481-01 |
NDC Item | 84612048101 |
packaging | 1 SYRINGE in 1 CARTON (84612-481-01) / .8 mL in 1 SYRINGE |
BLA | BLA761024 |
FDA SPL set id | 858781 |
Labeler | Optum Health Solutions (Ireland) Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2025-01-01 |
Marketing status | ACTIVE |
NDC item 84612048102
NDC 9 | 84612-481 |
---|---|
NDC 10 | 84612-481-02 |
NDC Item | 84612048102 |
packaging | 2 SYRINGE in 1 CARTON (84612-481-02) / .8 mL in 1 SYRINGE |
BLA | BLA761024 |
FDA SPL set id | 858781 |
Labeler | Optum Health Solutions (Ireland) Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2025-01-01 |
Marketing status | ACTIVE |